Harrison, C. N., Vannucchi, A. M., Kiladjian, J., Al-Ali, H. K., Gisslinger, H., Knoops, L., . . . Barbui, T. (2017). Erratum: Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis. Leukemia.
Chicago-стиль цитированияHarrison, C N., et al. "Erratum: Long-term Findings From COMFORT-II, a Phase 3 Study of Ruxolitinib Vs Best Available Therapy for Myelofibrosis." Leukemia 2017.
MLA-цитированиеHarrison, C N., et al. "Erratum: Long-term Findings From COMFORT-II, a Phase 3 Study of Ruxolitinib Vs Best Available Therapy for Myelofibrosis." Leukemia 2017.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.